The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers

Affiliations

• ¹ Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
• ² Institute of Pharmacy, Pharmacology & Toxicology, University of Bonn, Bonn, Germany.
• ³ Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁴ Molecular Biology of Breast Cancer, Heidelberg University Women's Hospital, Heidelberg, Germany.
• ⁵ Institute of Human Genetics, University of Bonn, Bonn, Germany.
• ⁶ Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
• ⁷ Central Cell Sort Facility, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
• ⁸ Division of Oncology, Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
• ⁹ Department of Obstetrics and Gynecology, University Medical Center Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
• ¹⁰ Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
• ¹¹ Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig, Germany.
• ¹² Department of Gynaecology and Obstetrics, Klinikum rechts der Isar at the Technical University, Munich, Germany.